// App-Quantinova.ai

: Resolution of Peripheral Neuropathy (PN) in Patients Who Received A+AVD or ABVD in the Phase 3 ECHELON-1 Trial

Researchers

Presenter

  • John Radford

Principal Investigators

  • Anas Younes

  • Andrea Gallamini

  • Stephen M. Ansell

  • Won Seog Kim

  • Ajay K. Gopal

  • Mark S Kaminski

  • June Won Cheong

  • Ian W. Flinn

  • Nagesh Kalakonda

  • Ruth Pettengell

  • Monika Dlugosz-Danecka

  • Gerald Engley

  • Keenan Fenton

  • Rachael Liu

  • Indra Purevjal

  • Harry Miao

  • Ashish Gautam

  • John Kuruvilla

Medical Centers

  • Manchester Academic Health Science Centre, University of Manchester, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

  • BC Cancer Centre for Lymphoid Cancer,Vancouver,Canadá

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Research Innovation and Statistics, Antoine-Lacassagne Cancer Centre, Nice, France

  • Mayo Clinic, Rochester, MN

  • Samsung Medical Center, seoul, CA, Korea, Republic of (South)

  • University of Washington Seattle Cancer Care Alliance, Seattle, WA

  • University of Michigan, Ann Arbor, MI

  • Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea, Republic of.

  • Sarah Cannon Research Institute, Nashville, TN

  • Department of Gastroenterology, University of Liverpool, Liverpool, United Kingdom

  • Guy's Hospital, London, United Kingdom

  • Department of Hematology, Jagiellonian University Hospital, Krakow, Poland

  • Seattle Genetics, Bothell, WA

  • Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Deerfield, IL

  • Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda, Cambridge, MA

Locations

  • United Kingdom

  • Canada

  • United States

  • France

  • Republic of South Korea

  • Poland

Companies

  • Seattle Genetics, In

  • Millennium Pharmaceu

Study Components

Therapeutic Area

  • Peripheral Nervous System

Disease

  • Peripheral neuropathy

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved